JAK inhibition in PD-1 immunotherapy and tumor microenvironment
Yang Liu(Nanchang University), Chao Zhang(Sun Yat-sen University), Ying Qin(Second Affiliated Hospital of Jilin University), Zhuming Lu(Jiangmen Central Hospital), Lianfang Zhao(Suizhou Central Hospital), Hongyu Chu(Jilin University), Jiaqi Liu(Sun Yat-sen University), Shengshan Xu(Jiangmen Central Hospital)
Cited by 0
Related Papers
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
|Cell|2025|103
Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response
|BMC Cancer|2024|50
The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis
|Journal of Inflammation Research|2025|48
Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer
|Frontiers in Immunology|2024|45